07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
03 Jan 2019

IN.PACT ADMIRAL:  MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

  Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the

0
12 Oct 2018

CYBER ATTACK FEAR LEADS TO MEDTRONIC DISABLING PACEMAKER INTERNET UPDATE

  Medtronic has disabled the internet update functionality of two of its CareLink devices used to program pacemaker implants amid concerns that they may be susceptible to cyberattacks, according to a letter from the medtech giant to healthcare professionals. Vulnerabilities had been identified in the update download process that could allow an individual

0